title: Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital.
abstract: BACKGROUND
  Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are an important cause of acute hospital admissions and incur significant costs, which include antibiotic costs.
  
  
  OBJECTIVE
  This study aimed to (i) define antibiotic prescribing practice in patients admitted to a tertiary hospital with AECOPD and compare this with current locally and nationally recognised antibiotic prescribing guidelines and (ii) correlate variations in guideline-concordant antibiotic prescribing with mean length of stay (LOS) and rates of unplanned readmission to hospital.
  
  
  METHODS
  Retrospective case series of 84 consecutive patients with uncomplicated AECOPD who met pre-specified selection criteria.
  
  
  RESULTS
  Seventy-two of 84 participants (85.7%) received guideline-discordant antibiotics, of whom the majority (76%) received intravenous antibiotics. Mean LOS was significantly lower among patients receiving guideline-concordant therapy compared with those receiving guideline-discordant therapy (mean 1.6 days vs 3.7 days; P = 0.002). There was no significant difference between groups in rates of readmission. Estimated excess costs per patient associated with guideline-discordant therapy equalled $2642 which, if eliminated, would save approximately $300 000 per annum.
  
  
  CONCLUSIONS
  In a tertiary hospital, Australian guidelines for treating patients with an AECOPD were rarely followed. The use of guideline-discordant therapy resulted in longer hospital stays and incurred greater costs. Studies are required to determine the reasons behind such discordant practice and to develop initiatives to improve antibiotic prescribing.
authors: School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
authors: M
authors: M
authors: Fanning
authors: M
authors: M
authors: McKean
authors: K
authors: K
authors: Seymour
authors: P
authors: P
authors: Pillans
authors: I
authors: I
authors: Scott
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000191:economics; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000191:economics; D001315:Australia / Q000453:epidemiology; D018450:Disease Progression; D005260:Female; D019983:Guideline Adherence; D006192:Haemophilus Infections / Q000517:prevention & control*; D017048:Health Care Costs; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D010102:Oxygen Inhalation Therapy / Q000191:economics / Q000706:statistics & numerical data; D010359:Patient Readmission / Q000706:statistics & numerical data; D011008:Pneumococcal Infections / Q000517:prevention & control*; D011552:Pseudomonas Infections / Q000517:prevention & control*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000517:prevention & control*; D062606:Tertiary Care Centers / Q000706:statistics & numerical data
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents
keywords: antibacterial agent; chronic obstructive; guideline adherence; hospital; outcomes assessment; pulmonary disease